Toll-like receptors (TLRs) serve as the body's first line of defense, recognizing both
pathogen-expressed molecules and host-derived molecules released from damaged or …

The tumor microenvironment (TME) is emerging as one of the primary barriers in cancer
therapy. Cancer-associated fibroblasts (CAF) are a common inhabitant of the TME in several …

The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in
Europe and the USA in recent decades. Among the different subtypes of liver cancers …

Primary liver cancer (PLC) includes hepatocellular carcinoma and intrahepatic
cholangiocarcinoma and is the sixth most common cancer worldwide with poor prognosis …

Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and the
third leading cause for cancer‐related death worldwide. The tumor is difficult‐to‐treat due to …

Chemoresistance in hepatocellular carcinoma (HCC) has been found to be influenced by
exosomal transport of circRNAs. However, the role of circZFR in HCC chemoresistance still …

Oxygen (O2) is essential for cellular metabolism and biochemical reactions. When the
demand for O2 exceeds the supply, hypoxia occurs. Hypoxia-inducible factors (HIFs) are …

Hepatocellular carcinoma (HCC) is one of the most common cancers with a relatively high
cancer-related mortality. The uncontrolled proliferation of HCC consumes a significant …

Hepatocellular carcinoma (HCC) is the second leading cause of death due to cancer.
Although there are different treatment options, these strategies are not efficient in terms of …

Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology Communications
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …